Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome.
about
The Right Ventricular Function After Left Ventricular Assist Device (RVF-LVAD) study: rationale and preliminary resultsComplications of Continuous-Flow Mechanical Circulatory Support Devices.The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates.Predictors of right ventricular failure after left ventricular assist device implantation.Right ventricular function and left ventricular assist device placement: clinical considerations and outcomes.Implantable continuous-flow right ventricular assist device: lessons learned in the development of a cleveland clinic device.Current status of mechanical circulatory assistance.Development of DexAide right ventricular assist device: update IIAssessment of right ventricular function in left ventricular assist device candidates.Right heart failure post left ventricular assist device implantation.Mechanical bridge to decision: what are the options for the management of acute refractory cardiogenic shock?Pharmacotherapy for mechanical circulatory support: a comprehensive review.Imaging in patients after cardiac transplantation and in patients with ventricular assist devices.Treatment and Prognosis of Pulmonary Hypertension in the Left Ventricular Assist Device Patient.Mechanical circulatory support for right heart failure: current technology and future outlook.Clinical Outcomes of Patients Treated With Pulmonary Vasodilators Early and in High Dose After Left Ventricular Assist Device Implantation.The inodilator levosimendan as a treatment for acute heart failure in various settings.The risk of right ventricular failure with current continuous-flow left ventricular assist devices.Reviewing the use of ventricular assist devices in the elderly: where do we stand today?Role of percutaneous veno-arterial extracorporeal membrane oxygenation as bridge to left ventricular assist device.
P2860
Q30359726-4E2998C0-8C6C-4AD5-A9AB-CA6467CF9235Q30409848-76C92115-2F83-479D-909B-9341D91A021EQ33743667-6725F0DD-D42D-48FE-95E3-336C5775FA2FQ34965572-7F93CF60-F735-4B68-A895-BD690D39591FQ34986270-FB652584-E190-4F20-BBD5-52BE67DD5A60Q36247354-13C3407E-625E-488F-9663-A8D7DAD48089Q36915732-04A68AD1-2F0B-4E8C-80E2-1F4980D31235Q37182052-6B5D3357-E8A2-4EC6-9C6E-0A541DFFC2D4Q37653938-59D1BC98-29D9-489D-B3CD-E24C57823CF7Q37663891-8AA8D126-DDF2-4A87-84B7-767973F4006CQ37821349-FA7E853F-435C-496F-BC83-793DFB78F689Q37826020-3FA5EB79-957A-40A4-93B5-72A734DE406DQ38400561-B1E76AAD-BC9B-4DE9-9E67-4CE3BD4F2635Q38848544-A8679EFB-ABC5-4D98-9892-D0A314E1C163Q39677870-AB505BDA-2315-4D7F-B12C-2CF3EC813993Q41725903-335BCA1C-EF04-498A-8463-3B9815FB4EC7Q47097922-E3D9A6D0-8AAE-41F7-8FD4-5159FB594024Q47316522-4D1A0DCE-70B4-4BD5-81E9-02B892803ED6Q47577914-37647A9E-CEA3-4A71-B8C0-21B458E8B1BBQ47717577-8E3DDE1E-0111-4FF5-987F-BDB341CCA8F7
P2860
Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Duration of inotropic support ...... factors and impact on outcome.
@en
Duration of inotropic support ...... factors and impact on outcome.
@nl
type
label
Duration of inotropic support ...... factors and impact on outcome.
@en
Duration of inotropic support ...... factors and impact on outcome.
@nl
prefLabel
Duration of inotropic support ...... factors and impact on outcome.
@en
Duration of inotropic support ...... factors and impact on outcome.
@nl
P2093
P1476
Duration of inotropic support ...... factors and impact on outcome.
@en
P2093
Eugene H Blackstone
Jingyuan Feng
Jose L Navia
Katherine J Hoercher
Kiyotaka Fukamachi
Lingmei Zhou
Nicholas G Smedira
Patrick M McCarthy
Soren Schenk
P304
P356
10.1016/J.JTCVS.2005.09.031
P407
P577
2006-02-01T00:00:00Z